eCite Digital Repository

Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis


Zhou, Y and Graves, JS and Simpson, S and Charlesworth, JC and van der Mei, I and Waubant, E and Barcellos, LF and Belman, A and Krupp, L and Lucas, R and Ponsonby, A-L and Taylor, BV, Ausimmmune/AusLong investigators group, Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis, Journal of Neurology, Neurosurgery and Psychiatry, 88, (10) pp. 864-868. ISSN 0022-3050 (2017) [Refereed Article]

Copyright Statement

2017 Article authors

DOI: doi:10.1136/jnnp-2017-315971


Background: Due to the lack of prospective studies with longitudinal data on relapse, past genetic studies have not attempted to identify genetic factors that predict relapse risk (the primary endpoint of many pivotal clinical trials testing the efficacy of multiple sclerosis (MS) disease-modifying drugs) at a genome-wide scale.

Methods: We conducted a genome-wide association analysis (GWAS) to identify genetic variants that predict MS relapse risk, using a three-stage approach. First, GWAS was conducted using the southern Tasmania MS Longitudinal Study with 141 cases followed prospectively for a mean of 2.3 years. Second, GWAS was conducted using the Ausimmune Longitudinal Study with 127 cases having a classic first demyelinating event followed for 5 years from onset. Third, the top hits with p<5.010-6 from the first two stages were combined with a longitudinal US paediatric MS cohort with 181 cases followed for 5 years after onset. Predictors of time to relapse were evaluated by a mixed effects Cox model. An inverse variance fixed effects model was then used to undertake a meta-analysis.

Results: In the pooled results, using these three unique longitudinal MS cohorts, we discovered one novel locus (LRP2; most significant single nucleotide polymorphism rs12988804) that reached genome-wide significance in predicting relapse risk (HR=2.18, p=3.3010-8). LRP2 is expressed on the surface of many central nervous system cells including neurons and oligodendrocytes and is a critical receptor in axonal guidance.

Conclusions: The finding of a genetic locus that has extensive effects on neuronal development and repair is of interest as a potential modulator of MS disease course.

Item Details

Item Type:Refereed Article
Keywords:CNS, LRP2, disease progression, multiple sclerosis, relapse risk
Research Division:Biomedical and Clinical Sciences
Research Group:Neurosciences
Research Field:Central nervous system
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Zhou, Y (Mr Yuan Zhou)
UTAS Author:Simpson, S (Dr Steve Simpson JR)
UTAS Author:Charlesworth, JC (Dr Jac Charlesworth)
UTAS Author:van der Mei, I (Professor Ingrid van der Mei)
UTAS Author:Taylor, BV (Professor Bruce Taylor)
ID Code:121331
Year Published:2017
Web of Science® Times Cited:11
Deposited By:Menzies Institute for Medical Research
Deposited On:2017-09-23
Last Modified:2022-08-23

Repository Staff Only: item control page